Category: News
Categories
Nutrix receives funding from Evig Alfa
Nutrix, a Swiss medical technology startup, was awarded the EVIG Alfa equity fund, which financially supports innovative projects at an early stage of development, and which is financed by private investors and capital from National Center for Research and Development.
EVIG Alfa’s investment will be used by Nutrix to develop software and AI algorithms that help monitor the glucose present in saliva in the treatment of diabetes. The overriding goal of the start-up is to use the full potential of artificial intelligence to give people the ability to monitor their health in an easy, non-invasive and painless way.
“ We are very pleased with this demonstration of trust as it brings us closer to our goal of ensuring the well-being of patients with chronic diseases such as diabetes, which affects 10% to 12% of the population in European countries,” said Maria Hahn, CEO of Nutrix.
Nutrix has been selected by TechCrunch as TC Top Picks for outstanding early-stage startups! One of three global startups in Health Tech!
In April 2020, Nutrix has won Venture Kick‘s financial and entrepreneurial support, together with other four startups.
Read here the full article about Nutrix’s win on Venture Kick’s web-page.
Nutrix has been featured on a recent article on the Massachussets Institute of Technology (MIT) News page.
Nutrix confirmed its attendance to the ATTD (Advanced Treatment & Technologies for Diabetes) international conference that will take place in Madrid, Spain from February 19th to 22nd.
The ATTD is a unique Conference that provides a world-class platform for clinicians and scientists to present, discuss and exchange insights on the most rapidly evolving area of diabetes technology and treatments. ATTD 2020 ( The 13th International Conference on Advanced Technologies & Treatments for Diabetes ) will showcase the latest, world-changing, innovations and research in Technologies & Treatments for Diabetes.
If you are attending the conference and wish to schedule an appointment with Nutrix, please reach out to us by email.
You can find here the full list of sponsors and exhibitors.
Nutrix has been selected by BaselArea.swiss as one of the six participants in the DayOne Accelerator programme, which caters Digital Health startups promoting the health of children and young people.
Out of the six participants, four will receive non-dilutive funding of 50,000 Swiss francs. All the participants will benefit from BaselArea.swiss, which is providing support by connecting them to a network of potential partners and customers, including the particularly distinguished University Children’s Hospital Basel (UKBB).
A total of 120 startups applied to the competition, and 14 were shortlisted. These companies worked in part with UKBB to develop their business ideas, before six were chosen by a panel of experts from the region to progress to the accelerator. One of the participants is the Basel company Nutrix, which is developing a nanosensor for glucose monitoring in saliva to prevent diabetes.
Further reading:
Here is a collection of the main international press releases covering Nutrix’s win at Web Summit 2019 Pitch contest.
EU Startups
Nutrix glycose level measurement device wins pitch competition at Web Summit 2019.
Expresso
Último dia de Web Summit: entre políticos que mostram a sua fibra e robôs que se transformam em atletas.
Nutrix: Nanossensor para diabéticos ganha concurso de startups da Web Summit.
SIC Noticias
Dispositivo para quem sofre de diabetes vence concurso de startups na Web Summit.